FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311508889> ?p ?o ?g. }

• W4311508889 abstract "Osteoarthritis (OA) is one of the most prevalent chronic degenerative joint diseases affecting adults in their middle or later years. It is characterized by symptoms such as joint pain, difficulty in movement, disability, and even loss of motion. Moreover, the onset and progression of inflammation are directly associated with OA. In this research, we evaluated the impact of Flavokawain A (FKA) on osteoarthritis. In-vitro effects of FKA on murine chondrocytes have been examined using cell counting kit-8 (CCK-8), safranin o staining, western blot, immunofluorescence staining, senescence β-galactosidase staining, flow cytometry analysis, and mRFP-GFP-LC3 adenovirus infection. An in-vivo model of destabilization of the medial meniscus (DMM) was employed to investigate FKA’s effect on OA mouse. An analysis of bioinformatics was performed on FKA and its potential role in OA. It was observed that FKA blocked interleukin (IL)-1β-induced expression of inflammatory factors, i.e., cyclooxygenase-2 (COX2) and inducible nitric oxide synthase (iNOS) in chondrocytes. In addition, FKA also downregulated the catabolic enzyme expression, i.e., aggrecanase-2 (ADAMTS5) and matrix metalloproteinases (MMPs), and helped in the upregulation of the anabolic protein expression, i.e., type II collagen (Col2), Aggrecan, and sry-box transcription factor 9 (SOX9). Moreover, FKA ameliorated IL-1β-triggered autophagy in chondrocytes, and it was observed that the FKA causes anti-inflammatory effects by the mitogen-activated protein kinase (MAPK) and phosphoinositide-3-kinase/Akt/mammalian target of rapamycin (PI3K/AKT/mTOR) signaling pathways inhibition. The results of immunohistochemical analysis and microcomputed tomography from the in vivo OA mouse model confirmed the therapeutic effect of FKA. Finally, we assessed the anti-arthritic impacts of FKA by conducting in vivo and in vitro analyses. We concluded that FKA can be employed as a useful therapeutic agent for OA therapy, but the findings require needs further clinical investigation." @default.
• W4311508889 created "2022-12-26" @default.
• W4311508889 creator A5000624318 @default.
• W4311508889 creator A5013934813 @default.
• W4311508889 creator A5014642249 @default.
• W4311508889 creator A5026388246 @default.
• W4311508889 creator A5036350345 @default.
• W4311508889 creator A5036598022 @default.
• W4311508889 creator A5050706937 @default.
• W4311508889 creator A5051653767 @default.
• W4311508889 creator A5060889491 @default.
• W4311508889 creator A5066226919 @default.
• W4311508889 creator A5071580093 @default.
• W4311508889 date "2022-12-05" @default.
• W4311508889 modified "2023-10-18" @default.
• W4311508889 title "Flavokawain A alleviates the progression of mouse osteoarthritis: An in vitro and in vivo study" @default.
• W4311508889 cites W1989563253 @default.
• W4311508889 cites W2043870138 @default.
• W4311508889 cites W2053342448 @default.
• W4311508889 cites W2058435889 @default.
• W4311508889 cites W2066868344 @default.
• W4311508889 cites W2079145795 @default.
• W4311508889 cites W2095689910 @default.
• W4311508889 cites W2100261712 @default.
• W4311508889 cites W2106416119 @default.
• W4311508889 cites W2139853056 @default.
• W4311508889 cites W2154461664 @default.
• W4311508889 cites W2166016039 @default.
• W4311508889 cites W2507683743 @default.
• W4311508889 cites W2560957403 @default.
• W4311508889 cites W2582214777 @default.
• W4311508889 cites W2743405616 @default.
• W4311508889 cites W2765466053 @default.
• W4311508889 cites W2776039151 @default.
• W4311508889 cites W2886676918 @default.
• W4311508889 cites W2902807504 @default.
• W4311508889 cites W2905436494 @default.
• W4311508889 cites W2915488153 @default.
• W4311508889 cites W2917542703 @default.
• W4311508889 cites W2946111889 @default.
• W4311508889 cites W2982947628 @default.
• W4311508889 cites W3017145197 @default.
• W4311508889 cites W3034735374 @default.
• W4311508889 cites W3048586480 @default.
• W4311508889 cites W3093238292 @default.
• W4311508889 cites W3101423962 @default.
• W4311508889 cites W3128653999 @default.
• W4311508889 cites W3156599923 @default.
• W4311508889 cites W3159695119 @default.
• W4311508889 cites W3204520392 @default.
• W4311508889 cites W3207105154 @default.
• W4311508889 cites W3215497458 @default.
• W4311508889 cites W4211069396 @default.
• W4311508889 cites W4232024554 @default.
• W4311508889 cites W4285403931 @default.
• W4311508889 cites W4286750340 @default.
• W4311508889 doi "https://doi.org/10.3389/fbioe.2022.1071776" @default.
• W4311508889 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36545678" @default.
• W4311508889 hasPublicationYear "2022" @default.
• W4311508889 type Work @default.
• W4311508889 citedByCount "1" @default.
• W4311508889 countsByYear W43115088892023 @default.
• W4311508889 crossrefType "journal-article" @default.
• W4311508889 hasAuthorship W4311508889A5000624318 @default.
• W4311508889 hasAuthorship W4311508889A5013934813 @default.
• W4311508889 hasAuthorship W4311508889A5014642249 @default.
• W4311508889 hasAuthorship W4311508889A5026388246 @default.
• W4311508889 hasAuthorship W4311508889A5036350345 @default.
• W4311508889 hasAuthorship W4311508889A5036598022 @default.
• W4311508889 hasAuthorship W4311508889A5050706937 @default.
• W4311508889 hasAuthorship W4311508889A5051653767 @default.
• W4311508889 hasAuthorship W4311508889A5060889491 @default.
• W4311508889 hasAuthorship W4311508889A5066226919 @default.
• W4311508889 hasAuthorship W4311508889A5071580093 @default.
• W4311508889 hasBestOaLocation W43115088891 @default.
• W4311508889 hasConcept C142724271 @default.
• W4311508889 hasConcept C185592680 @default.
• W4311508889 hasConcept C190283241 @default.
• W4311508889 hasConcept C197534660 @default.
• W4311508889 hasConcept C203522944 @default.
• W4311508889 hasConcept C204787440 @default.
• W4311508889 hasConcept C2776164576 @default.
• W4311508889 hasConcept C3020332539 @default.
• W4311508889 hasConcept C502942594 @default.
• W4311508889 hasConcept C55493867 @default.
• W4311508889 hasConcept C57074206 @default.
• W4311508889 hasConcept C62478195 @default.
• W4311508889 hasConcept C71924100 @default.
• W4311508889 hasConcept C75217442 @default.
• W4311508889 hasConcept C86554907 @default.
• W4311508889 hasConcept C86803240 @default.
• W4311508889 hasConcept C95444343 @default.
• W4311508889 hasConceptScore W4311508889C142724271 @default.
• W4311508889 hasConceptScore W4311508889C185592680 @default.
• W4311508889 hasConceptScore W4311508889C190283241 @default.
• W4311508889 hasConceptScore W4311508889C197534660 @default.
• W4311508889 hasConceptScore W4311508889C203522944 @default.
• W4311508889 hasConceptScore W4311508889C204787440 @default.
• W4311508889 hasConceptScore W4311508889C2776164576 @default.
• W4311508889 hasConceptScore W4311508889C3020332539 @default.

• next